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A review of cardiac tumors
This historical perspective highlights two points of interest concerning 
the present-day diagnosis of cardiac tumors: the frequent clinical 
misdiagnosis as rheumatic heart disease, and the crucial role of 
echocardiography.  
The high prevalence of rheumatic heart disease in South Africa accounts 
for the common misdiagnosis at primary care level of cardiac tumors as 
mitral valve pathology. Patients are initially investigated by 
echocardiography, a “screening” investigation with inherent operator 
dependent notoriety. The diagnosis of an intracardiac mass then 
provokes referral to a tertiary cardiology service for detailed 
investigation and subsequent surgical consideration.   
The clinical incidence of primary cardiac tumors is about 1 in 500 
cardiac surgical cases and, with the exception of myxoma, will rarely be 
encountered in the career span of the average cardiologist or 
cardiothoracic surgeon.(1)  The extensive use of imaging modalities such 
as CT scan and MRI in the investigation of unrelated disease, or in 
screening a “well patient”, occasionally reveals an incidental cardiac 
tumor.(3)  The radiographic characteristics of various cardiac tumors are 
well described and a few are illustrated in this review.  
Surgery is often undertaken with a presumptive diagnosis predicated 
on the clinical presentation, echocardiographic and radiographic 
features. The intraoperative fi ndings are often pathognomonic, with 
occasional exceptions. Histopathology and immunohistochemistry 
establishes the defi nitive answer and directs further management.
LOCAL EXPERIENCE
In the past 4 years, surgeons in the cardiothoracic unit at IALCH 
collectively excised 13 tumors within the pericardium. Tumor excision 
was occasionally combined with ancillary procedures, including mitral 
valve replacement, and nephrectomy.  In addition, intracardiac masses 
encountered without excision included right ventricular thrombus, 
metastatic melanoma, neonatal rhabdomyoma and advanced bronchial 
carcinoma with left atrial invasion (Figure 1).  
Nine atrial myxomas were excised using a biatrial approach.  Of note, 
one myxoma was diagnosed incidentally, in a patient without cardio-
respiratory symptoms, by CT scan for investigation of renal calculi.  Four 
patients were mistaken clinically for rheumatic valvular disease, with 
revision to myxoma made on echocardiogram. 
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  The intention of the review is to highlight 
the clinical presentation and established surgical technique 
in the management of this relatively uncommon cardiac 
pathology.  
Intracardiac masses may be encountered by a cardiologist 
or cardiac surgeon, and a comprehensive knowledge of the 
various diagnostic modalities is therefore essential. More 
crucial are the likely probabilities, based on an amalga-
mation of the clinical features, echocardiographic and 
radiographic fi ndings. If surgical management is under-
taken, the intra-operative fi nding is ultimately correlated 
with the histopathological diagnosis.  
In the review, we emphasise the necessity of a multi-
disciplinary approach to management of these tumors. The 
cumulative experience of the various members of the team 
collectively enables increasingly accurate diagnoses to be 
made preoperatively, with appropriate surgical management 
carried out timeously.  SAHeart 2008; 5:116-122
ABSTRACT
CARDIAC  TUMORS
INTRODUCTION                                                                 
In 1954 the fi rst successful excision of a cardiac tumor was described. 
Utilising fi brillatory arrest via thoracotomy, Crafoord successfully 
resected a left atrial myxoma from a 40-year-old woman initially 
referred for atypical mitral stenosis.(1) Prior to the late 1950s, 
most cardiac tumors were discovered at postmortem examination. 
The development of echocardiography demonstrated the fi rst echo 
diagnosis of an intracardiac tumor in 1959, thereby facilitating 
subsequent surgical referral and management.(2)  
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The following vignettes illustrate some of the protean modes of 
presentation and occasional diagnostic quandary associated with these 
uncommon tumors.  
Case 1
A 33-year-old African female presented with intermittent swelling of 
the lower limbs and clinical features of signifi cant mitral valve 
regurgitation, confi rmed echocardiographically with leafl et thickening 
and calcifi cation.  Left ventricular contractility was good with an ejection 
fraction of 68%, systolic and diastolic dimensions of 38mm and 62mm 
respectively.  Coincidentally, a 4.2 x 4.8 cm homogenous mass was seen 
in the right atrium, attached to the free wall.  The tricuspid valve leafl ets 
were normal with mild eccentric tricuspid regurgitation. Symptoms 
were ascribed to mitral regurgitation and necessitated surgery.  
At operation, on opening the pericardium, the mass was easily 
visualized and thought to be a well encapsulated lipoma arising from 
the right atrial free wall (Figure 2) and suitable for excision with a cuff 
of right atrium (Figure 3) and direct suture closure of the defect.  Via a 
left atriotomy the mitral valve was replaced with a mechanical prosthesis. 
Histology confi rmed a completely resected encapsulated lipoma 
(Figure 4) and the valve showed features of chronic rheumatic valvulitis, 
with no evidence of infective endocarditis.  
Case 2
A 2-day-old neonate was referred to the tertiary neonatal intensive 
care unit following mechanical ventilation for progressively worsening 
respiratory distress 6 hours after caesarian section for prolonged labour, 
with APGAR scores of 8 and 9 at one and fi ve minutes respectively. 
Antenatal routine foetal ultrasound had detected fl uid within the 
thoracic cavity without clear visualization of the 4 cardiac chambers. 
Plain chest radiography on Day 1 showed a markedly enlarged 
mediastinal silhouette (Figure 5), and echocardiography confi rmed a 
pericardial effusion (20mm anteriorly, 13mm posteriorly and 5mm 
apically) and a large intrapericardial mass. A CT scan was done for 
further elucidation (Figure 6). This showed a large, homogenous soft 
FIGURE 3: Lipoma excised with margin of right atrial free wall.
FIGURE 4: Cut section of encapsulated cardiac lipoma.
FIGURE 1: Left atrial invasion (arrow) from bronchial carcinoma. FIGURE 2: Right atrial lipoma (arrow) in situ.
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tissue mass within the pericardium measuring 53mm x 41mm. At 
operation, via median sternotomy, in addition to the serous pericardial 
collection, a large homogenous soft tissue mass arising from the anterior 
myocardium of the left ventricle was encountered (Figure 7).  Attempts 
at dissection of the tumor proved futile. The procedure was 
therefore abandoned in favour of multiple core needle biopsies. 
Histopathology and immunohistochemistry were consistent with a 
cardiac rhabdomyoma. She is currently being investigated for tuberous 
sclerosis, known to be associated with cardiac rhabdomyomas.(4)  
Case 3
A 4-year-old child with stage IV nephroblastoma was referred for 
excision of residual tumor within the IVC and right atrium. The child had 
undergone right nephrectomy 4 weeks previously and had been 
commenced on chemotherapy in the interim. CT scan prior to 
nephrectomy demonstrated the large right renal mass with right atrial 
extension of tumor (Figure 8). Echocardiography showed tumor 
(measuring 48mm x 33m) within the inferior vena cava extending into 
the right atrium. Surgery was undertaken with deep hypothermic 
(16 degrees centigrade) circulatory arrest. Via the right atrium residual 
tumor, densely adherent to the interatrial septum and IVC, was dissected 
and excised. Complete excision of IVC and right atrial tumor was 
confi rmed with a post operative CT scan.  Histology was consistent 
with metastatic nephroblastoma.  
Case 4
A 14-year-old male was referred from the Department of Oncology 
with congestive cardiac failure.  Two years previously he had undergone 
an above-knee amputation for osteogenic sarcoma and was currently 
on chemotherapy via an indwelling central venous catheter (Groshong 
line).  Plain chest radiography demonstrated bilateral pleural collections 
and an enlarged cardiac silhouette, in keeping with congestive cardiac 
failure. Aspiration revealed serous effusions with no malignant cells. 
Echocardiogram demonstrated a large right ventricular mass, illustrated 
by CT scan of the thorax and thought to represent a thrombus 
intimately associated with the central venous catheter (Figure 9). The 
patient declined intervention.
FIGURE 8: Right atrial spread of nephroblastoma (arrow).
FIGURE 9: Right ventricular mass (arrow) associated with long-term indwelling 
central venous line.
FIGURE 5: Markedly enlarged cardiac silhouette. FIGURE 6: Intrapericardial mass (large arrow) with 
associated pericardial effusion (small arrow).
FIGURE 7: Rhabdomyoma (arrow) arising within ventricular muscle.
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PATHOLOGICAL CLASSIFICATION
Cardiac tumors may be classifi ed as primary (benign or malignant) 
or secondary neoplasms that have metastasized to the heart. The 
incidence of primary cardiac neoplasms in random autopsy series 
ranges between 0.17-0.19%.(5) Secondary involvement of the heart or 
pericardium occurs in 10-20% of patients with disseminated cancer.(6) 
In addition to metastases, contiguous spread from pulmonary or 
mediastinal tumors may result in invasion of intrapericardial structures.
Approximately 75% of primary cardiac tumors are benign, with half 
of this group comprising myxomas. Myxomas are the commonest 
primary cardiac tumors.(7) In infants and children, the most common 
primary cardiac tumor is a rhabdomyoma. Sarcomas make up 75% 
of primary malignant tumors, with angiosarcoma being commonest.(8)
MYXOMA
This entity merits special attention as it is the commonest cardiac 
neoplasm, representing 50% of all benign cardiac tumors.(9)  The peak 
incidence is between the 3rd and 6th decades, with a female 
preponderance.(10)  
Myxomas arise from the endocardial mesenchyme and consist of a 
polysaccharide matrix made up of smooth muscle, collagen and 
elastin.(11)  The macroscopic appearance is either gelatinous, lobulated 
or smooth.(12)  They may manifest in sessile, polypoid or pedunculated 
form. Approximately two-thirds of myxomas are polypoid, with a 
smooth, lobulated surface and are unlikely to break off spontaneously 
(Figure 10).(13) The remainder, by contrast, are of the villous variety with 
a gelatinous consistency, and a propensity for fragmentation and 
embolization (Figure 11). In addition to an overall fi rm consistency, 
some myxomas demonstrate gross calcifi cation, which may form the 
bulk of the tumor.  This condition is referred to as “petrifi ed cardiac 
myxoma” and may be mistaken for an atrial thrombus.(7) 
Rhabdomyoma Rhabdomyosarcoma
Fibroma Angiosarcoma
Myxoma Malignant fi brous histiocytoma
Hemangioma Leiomyosarcoma
Mesothelioma of AV node Fibrosarcoma
Purkinje cell tumor Myxosarcoma
Teratoma Unclassifi ed
   Infancy and childhood (< 16 years old)
  Benign  Malignant
Primary cardiac tumors *
Melanoma Renal cell carcinoma
Sarcoma Nephroblastoma
 Bronchial carcinoma
  Benign  Malignant
Secondary cardiac tumors 
Myxoma Angiosarcoma
Papillary fi broelastoma Malignant fi brous histiocytoma
Hemangioma Osteosarcoma
Lipomatous hypertrophy (atrial septum) Leiomyosarcoma







   Adult
  Benign  Malignant
*Adapted from:  Tumors of the heart and pericardium, Diagnostic histopathology of tumors 2nd ed, 
Ch.D.M. Fletcher.
FIGURE 11: Villous, gelatinous myxoma with increased propensity for fragmentation 
and distal embolization.
FIGURE 10: Polypoid, lobulated myxoma with adherent fi brin.  This “solid” variety 
is less likely to fragment spontaneously.  
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While the overwhelming majority of myxomas occur sporadically, 5% 
have a familial pattern based on autosomal dominant inheritance.(14) 
The familial type often affl icts the young with equal gender distribution, 
and is often multicentric with a higher recurrence rate after surgery.(15) 
Myxomas may originate in any chamber:  75% occur in the left atrium 
and 10-20% in the right.(16) 94% of myxomas are solitary. They are 
known to arise from any part of the atrium including the atrial 
appendage.  Most arise from the interatrial septum at the border of the 
fossa ovalis. Generally, right atrial myxomas have broad-based 
attachments. Right ventricular lesions arise from the ventricular free 
wall whilst left ventricular myxomas arise from the posterior papillary 
muscle.(17)   
CLINICAL PRESENTATION OF CARDIAC TUMORS
As cardiac tumors are slow-growing neoplasms, most patients remain 
asymptomatic until the tumor has reached suffi cient proportion to 
cause complications. Incidental tumors are often detected during the 
investigation of other cardiac disease. Patients with cardiac tumors may 
be asymptomatic or present with constitutional symptoms, palpitations, 
congestive cardiac failure, thromboembolism or infection.  
The common constitutional features are: loss of weight, fever, lethargy, 
clubbing, arthralgia and myalgia. These may occur in association 
with hematological abnormalities including leucocytosis, increased 
erythrocyte levels and sedimentation rate, hemolytic anemia, 
thrombocytopenia, elevated C-reactive protein, increased circulating 
immunoglobulin G and interleukin-6.(18)  
Obstruction of cardiac blood fl ow is determined by the size of the 
tumor as well as the chamber involved.  Obstructive lesions in the left 
atrium tend to mimic mitral valve disease, predominantly mitral stenosis. 
Obversely, mitral regurgitation occurs when a voluminous tumor 
interferes with mitral leafl et coaption.  The clinical presentation may be 
that of cardiac failure with elevated left atrial and pulmonary venous 
pressures. Obstructive lesions in the right atrium simulate tricuspid 
valve stenosis and may produce the clinical features of right ventricular 
failure.  In the presence of a patent foramen ovale, right-to-left atrial 
shunting may occur with ensuing central cyanosis and the potential for 
paradoxical embolization. Ventricular tumors may cause outfl ow 
obstruction, mimicking subaortic, aortic or pulmonary valve stenosis.  
Systemic embolization occurs in 30-40% of patients with atrial 
myxomas.(19) With left-sided tumors, the majority of embolic episodes 
affect the central nervous system. Other areas include the lower limb, 
pulmonary, abdominal visceral, renal and coronary artery circulations.  
Infection occurring within a cardiac tumor is a rare phenomenon. The 
clinical picture resembles infective endocarditis and the increased risk of 
tumor embolisation constitutes an indication for urgent surgery.
DIFFERENTIAL DIAGNOSIS
The clinical features of an intracardiac mass causing interference with 
valvular function may simulate rheumatic valvular disease or infective 
endocarditis.  
The intrapericardial component of a bronchial or mediastinal tumor 
may be misinterpreted as a cardiac tumor if investigated initially by 
echocardiography for cardiac symptoms.  A mural thrombus may mimic 
an intracardiac mass both clinically and radiographically.(16) Mural 
thrombi are associated with myocardial infarction, atrial fi brillation with 
or without valve disease, long-term use of central venous catheters and 
hypercoaguable states.  
INVESTIGATIONS
Chest radiograph
The radiograph may appear normal or show features of abnormal 
cardiac silhouette, chamber enlargement, pulmonary congestion and 
congestive cardiac failure. Occasionally, calcifi cation may be visible in the 
tumor, particularly right-sided myxomas.    
Electrocardiogram
The electrocardiographic fi ndings are usually nonspecifi c and include 
chamber enlargement, cardiomegaly, bundle-branch block and axis 
deviation.  
Echocardiogram
The transthoracic echocardiogram usually provides adequate diagnostic 
information for surgical resection and is suffi ciently sensitive to predict 
the etiology of most intracavitary masses, especially myxoma. The 
transoesophageal echocardiogram provides superior defi nition of 
tumor size, location, mobility and attachment  and is also useful to 
evaluate the posterior left atrial wall, interatrial septum and the 
right atrium.(18) Intraoperative transoesophageal echocardiography also 
provides a useful means of confi rming adequate tumor resection. 
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Computed tomography
The use of computed tomography is greatest in the evaluation of 
malignant cardiac tumors because of its ability to demonstrate 
myocardial and extramyocardial tumor invasion.  
Magnetic resonance imaging (MRI)
This modality provides high-defi nition images of soft-tissue tumors and 
hence, may yield a comprehensive picture of tumor size, shape and 
surface characteristics. In addition, MRI is useful in detecting intracardiac 
and pericardial extension and invasion by malignant secondary 
tumors.(21)
INDICATIONS FOR SURGERY
The diagnosis of a primary cardiac tumor confi ned to the heart is, per 
se, an indication for surgery.  The timing of intervention is infl uenced by 
the presence of complications such as obstruction to cardiac blood 
fl ow, embolization and infection, mandating emergency surgery. An 
estimated 8% of patients die while awaiting surgery.(22)
SURGICAL STRATEGY
The heart and great vessels are customarily and best approached via a 
median sternotomy. During cannulation of the ascending aorta and 
vena cavae, it is vital to avoid cardiac manipulation to minimize the risk 
of precipitating tumor embolization.  
For left atrial tumors, the vena cavae are cannulated via the right atrium 
with the inferior vena caval cannula placed close and lateral to the 
inferior vena cava/right atrial junction.  
When a malignant left atrial tumor is suspected, or if extensive 
exposure is necessary, then the superior vena cava is cannulated 
directly.  This permits transection of the superior vena cava for additional 
exposure.
Right atrial tumors carry special cannulation considerations in view of 
the risk of tumor fragmentation and dislodgement. Both vena cavae 
may be cannulated directly. CT scan or MRI is useful to determine the 
extent of intravascular tumor spread as the presence of low or high-
lying tumor may necessitate cannulation of the femoral or jugular 
veins.
Cardiopulmonary bypass with mild to moderate hypothermia is 
instituted and the aorta cross-clamped prior to cardioplegic delivery. 
Atrial tumors may be approached either via the chamber of origin 
directly (atrial approach) or via a biatrial approach for tumors attached 
to the interatrial septum.(23) Entry into multiple chambers necessitates 
meticulous cardiac deairation prior to aortic declamping.  
Left atrial tumors may be approached via a standard transverse incision 
anterior to the right pulmonary veins. Exposure of large tumors 
attached to the interatrial septum may be facilitated by a parallel 
counter-incision in the right atrium, enabling the surgeon to locate the 
septal attachment. Left atrial tumors arising from the interatrial septum 
are also amenable to resection via a right atriotomy and trans-septal 
approach.
Ventricular tumors may be approached through the atrio-ventricular 
valve, which may be detached anteriorly to improve exposure. Access 
may also be obtained via a transvalvular approach or ventriculotomy.(24) 
In principle, it is desirable to resect the tumor en bloc without 
fragmentation as well as a full-thickness margin of the surrounding 
myocardium or septum to which it is attached.  The full-thickness defect 
is then reconstructed with either a patch of autologous pericardium or 
synthetic material.  In practice, only a partial thickness resection may be 
possible due to anatomical constraints such as underlying conduction 
tissue or valvular structures, accepting a concomitant increased risk of 
tumor recurrence. Recurrence is also postulated to be a result of 
incomplete atrial septectomy for tumors arising from the interatrial 
septum.(25)
Advanced surgical techniques for the excision of relatively inaccessible, 
locally invasive malignant tumors, such as malignant fi brous histio-
cytoma, include explantation of the heart with ex vivo aggressive 
resection and reconstruction of the left atrium. This technique has 
produced satisfactory results in experienced centres.(9)  
Following tumor excision, copious irrigation of the relevant cardiac 
chamber with evacuation of residual tumor fragments via the wall 
suction is essential to prevent systemic embolisation. The adjacent 
atrio-ventricular valve is then inspected for damage to the annulus, 
leafl ets or chordae, mindful of advocacy of valve repair and preservation. 
Should a multicentric tumor be suspected, then all four cardiac 




The utility of an intraoperative transoesophageal echocardiogram lies 
in the evaluation of the lesion, facilitation of safe cannulation, confi rma-
tion of complete tumor removal and assessment of the adequacy of 
repair and cardiac deairation.(26)  
LONG-TERM ECHOCARDIOGRAPHIC SURVEILLANCE
Long-term echocardiographic surveillance is indicated in the following 
instances:  tumors that are multicentric or present in unusual cardiac 
locations, incomplete tumor resection, abnormal tumor DNA genotype 
and myxoma with malignant histological characteristics.(24)
RESULTS
The operative mortality for benign tumors is less than 5%,(10) with a 1-
4% recurrence rate for myxomas of the sporadic type and a 22% 
recurrence rate for the familial type.(11) Recurrence rates and long-term 
survival for malignant tumors are contingent upon pathological tumor 
stage and biological characteristics of the tumor.
CONCLUSION
Interdepartmental collaboration for assessment of cardiac tumors is 
obligatory.  Key members of the management team include a cardiologist, 
radiologist, cardiac surgeon and pathologist. The use of enhanced 
radiographic imaging, intraoperative TEE and professional surgical 
photography promote interaction at various levels.  
A team approach leads to improved clinicopathological correlation and 
permits utilization of the available knowledge and skills.  If maximal 
information is extracted and analyzed from individual cases, the unit is 
able to collectively accumulate expertise on the local nuances of an 
uncommonly encountered condition.  
The unfortunate reality is that ancillary members tend to surreptitiously 
fall by the wayside (unless, of course, there is pecuniary interest) as the 
patient is wheeled into the operating room, and often it is only the 
surgical team that gains maximal exposure, including fi guratively, to the 
pathology. 
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